This Article Full Text Full Text (PDF) Data Supplement Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parsons-Wingerter, P. Articles by Farr, A. G. Search for Related Content PubMed PubMed Citation Articles by Parsons-Wingerter, P. Articles by Farr, A. G. Pubmed/NCBI databases Substance via MeSH Related Collections Angiogenesis

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1250.)
© 2000 American Heart Association, Inc.

Vascular Biology

Fibroblast Growth Factor-2 Selectively Stimulates Angiogenesis of Small Vessels in Arterial Tree

Patricia Parsons-Wingerter; Katherine E. Elliott; John I. Clark; Andrew G. Farr

From the Department of Biological Structure (P.P.-W., J.I.C., A.G.F.), University of Washington School of Medicine, Seattle, and the 3Com Corp (K.E.E.), Bellevue, Wash.

Correspondence to Patricia Parsons-Wingerter, PhD, Department of Anatomy and Cardiovascular Research Institute, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0130.

Abstract—There is a critical need for quantifiable models of angiogenesis in vivo, and in general, differential effects of angiogenic regulators on vascular morphology have not been measured. Because the potent angiogenic stimulators fibroblast growth factor (FGF)-2 (basic FGF) and vascular endothelial growth factor (VEGF) are reported to stimulate angiogenesis through distinct signaling pathways, we hypothesized that FGF-2 stimulates vascular morphology differently than does VEGF and that stimulation of angiogenesis by FGF-2 is directly correlated to FGF receptor density. FGF-2 was applied at embryonic day 7 (E7), E8, or E9 to the quail chorioallantoic membrane (CAM); subsequent response of the arterial tree was measured by the fractal dimension (D_f), a mathematical descriptor of complex spatial patterns, and by several generational branching parameters that included vessel length density (L_v). After application of FGF-2 at E7, arterial density increased according to D_f as a direct function of increasing FGF-2 concentration, and FGF-2 stimulated the growth of small vessels, but not of large vessels, according to L_v and other branching parameters. For untreated control specimens at E7, L_v of small vessels and D_f were 11.1±1.6 cm^-1 and 1.38±0.01, respectively; at E8, after treatment with 5 µg FGF-2/CAM for 24 hours, L_v of small vessels and D_f increased respectively to 22.8±0.7 cm^-1 and 1.49±0.02 compared with 16.3±0.9 cm^-1 and 1.43±0.02 for PBS-treated control specimens. Application of FGF-2 at E8 and E9 did not significantly increase arterial density. By immunohistochemistry, the expression of 4 high-affinity tyrosine kinase FGF receptors was significantly expressed at E7, when CAM vasculature responded strongly to FGF-2 stimulation, but FGF receptor expression decreased throughout the CAM by E8, when vascular response to FGF-2 was negligible. In conclusion, the "fingerprint" vascular pattern elicited by FGF-2 was distinct from vascular patterns induced by other angiogenic regulators that included VEGF₁₆₅, transforming growth factor-ß1, and angiostatin.

Key Words: quail • chorioallantoic membrane • fractal dimension • fibroblast growth factor receptors • complexity

This article has been cited by other articles:

				B. Lilly and S. Kennard Differential gene expression in a coculture model of angiogenesis reveals modulation of select pathways and a role for Notch signaling Physiol Genomics, January 8, 2009; 36(2): 69 - 78. [Abstract] [Full Text] [PDF]

				P. Vitorino and T. Meyer Modular control of endothelial sheet migration Genes & Dev., December 1, 2008; 22(23): 3268 - 3281. [Abstract] [Full Text] [PDF]

				A. Horowitz and M. Simons Branching Morphogenesis Circ. Res., October 10, 2008; 103(8): 784 - 795. [Abstract] [Full Text] [PDF]

				T. L. McKay, D. J. Gedeon, M. B. Vickerman, A. G. Hylton, D. Ribita, H. H. Olar, P. K. Kaiser, and P. Parsons-Wingerter Selective Inhibition of Angiogenesis in Small Blood Vessels and Decrease in Vessel Diameter throughout the Vascular Tree by Triamcinolone Acetonide Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1184 - 1190. [Abstract] [Full Text] [PDF]

				M. M. Fuster, L. Wang, J. Castagnola, L. Sikora, K. Reddi, P. H.A. Lee, K. A. Radek, M. Schuksz, J. R. Bishop, R. L. Gallo, et al. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis J. Cell Biol., May 7, 2007; 177(3): 539 - 549. [Abstract] [Full Text] [PDF]

				K. A. Detillieux, F. Sheikh, E. Kardami, and P. A. Cattini Biological activities of fibroblast growth factor-2 in the adult myocardium Cardiovasc Res, January 1, 2003; 57(1): 8 - 19. [Abstract] [Full Text] [PDF]

				C. J. Sullivan, T. Doetschman, and J. B. Hoying Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb J Appl Physiol, December 1, 2002; 93(6): 2009 - 2017. [Abstract] [Full Text] [PDF]

				W. Roethy, E. Fiehn, K. Suehiro, A. Gu, G. H. Yi, J. Shimizu, J. Wang, G. Zhang, J. Ranieri, R. Akella, et al. A Growth Factor Mixture That Significantly Enhances Angiogenesis in Vivo J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 494 - 500. [Abstract] [Full Text] [PDF]